Direct Biologics Reports Compelling Results From Phase 2 Trial With ExoFlo™ in Hospitalized Patients With Respiratory Failure or Moderate-to-Severe Acute Respiratory Distress Syndrome (ARDS) Due to ...
Acute respiratory distress syndrome (ARDS) is an emergency situation in both children and adults, as it compromises the vital oxygen supply to the body. A new study published in JAMA Network Open ...
Inhaled sevoflurane significantly reduced ventilator-free days and 90-day survival versus IV propofol in moderate to severe ARDS. Inhaled volatile sedatives grew in popularity for prolonged use in ...
Researchers may have discovered a mechanical explanation for instability observed in the lungs in cases of acute respiratory distress syndrome (ARDS), particularly in the aftermath of respiratory ...
Passive immunization with plasma collected from convalescent patients has been regularly used to treat coronavirus disease 2019 (Covid-19). Minimal data are available regarding the use of convalescent ...
Breathing troubles can feel frightening, especially when the cause is serious. Among the many lung conditions, two names that often come up are pneumonia and Acute Respiratory Distress Syndrome (ARDS) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results